Strategies for deriving predicted environmental concentrations (PECs) using environmental exposure models have become increasingly important in the environmental risk assessment of chemical substances. However, many strategies are not fully developed owing to uncertainties in the derivation of PECs across spatially extensive areas. Here, we used 3-year environmental monitoring data (river: 11 702 points; lake: 1867 points; sea: 12 points) on linear alkylbenzene sulfonate (LAS) in Japan to evaluate the ability of the National Institute of Advanced Industrial Science and Technology (AIST)-Standardized Hydrology-Based Assessment Tool for the Chemical Exposure Load (SHANEL) model developed to predict chemical concentrations in major Japanese rivers. The results indicate that the estimation ability of the AIST-SHANEL model conforms more closely to the actual measured values in rivers than it does for lakes and seas (correlation coefficient: 0.46; proportion within the 10× factor range: 82%). In addition, the 95th percentile, 90th percentile, 50th percentile, and mean values of the distributions of the measured values (14 µg/L, 8.2 µg/L, 0.88 µg/L, and 3.4 µg/L, respectively) and estimated values (19 µg/L, 13 µg/L, 1.4 µg/L, and 4.2 µg/L, respectively) showed high concordance. The results suggest that AIST-SHANEL may be useful in estimating summary statistics (e.g., 95th and 90th percentiles) of chemical concentrations in major rivers throughout Japan. Given its practical use and high accuracy, these environmental risk assessments are suitable for a wide range of regions and can be conducted using representative estimated values, such as the 95th percentile. Integr Environ Assess Manag 2019;15:750-759. © 2019 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals, Inc. on behalf of Society of Environmental Toxicology & Chemistry (SETAC).
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852430 | PMC |
http://dx.doi.org/10.1002/ieam.4167 | DOI Listing |
Pharmaceuticals (Basel)
January 2025
Institute of Physiology, Charité-Universitätsmedizin Berlin, Corporate Member of the Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, Germany.
Background/objectives: New drugs are required for the treatment of liver cancers and protozoal parasite infections. Analogs of the known anticancer active and antileishmanial 2',4',6'-trimethoxychalcone SU086 were prepared and investigated.
Methods: The chalcones were prepared according to the Claisen-Schmidt condensation protocol and analyzed.
Nat Biotechnol
January 2025
Insilico Medicine AI Limited, Abu Dhabi, UAE.
We introduce a quantum-classical generative model for small-molecule design, specifically targeting KRAS inhibitors for cancer therapy. We apply the method to design, select and synthesize 15 proposed molecules that could notably engage with KRAS for cancer therapy, with two holding promise for future development as inhibitors. This work showcases the potential of quantum computing to generate experimentally validated hits that compare favorably against classical models.
View Article and Find Full Text PDFCirc Cardiovasc Interv
January 2025
Division of Cardiovascular Medicine (E.Y., L.E., J.M.H., S.B.), New York University.
Background: The aim of this study was to examine the impact of early versus delayed catheter-based therapies (CBTs) on clinical outcomes in patients with acute intermediate-risk pulmonary embolism (PE).
Methods: This retrospective cohort study analyzed data from 2 academic centers involving patients with intermediate-risk PE from January 2020 to January 2024. Patients were divided into early (<12 hours) and delayed CBT (≥12 hours) groups.
Drugs Aging
January 2025
Department of Military and Emergency Medicine, Uniformed Services University, Bethesda, MD, USA.
Background: Untreated low back pain (LBP) in older adults can lead to disability and development of chronicity. Due to the potential development of medical comorbidities and negative risks associated with pharmacological use, chronic LBP management for older adults requires a responsive approach.
Methods: The objective of this study is to evaluate the probability of (1) opioid prescription receipt and (2) opioid-sedative coprescription, in a sample of military-service-connected patients enrolled in the Veterans Health Administration (VHA) or TRICARE, ages 30-85 years, receiving care in three systems: VHA, Military Health System (MHS), and nonfederal (civilian) healthcare facilities.
Pharmaceutics
December 2024
Department of Hospital Surgery, Department of Plastic and Reconstructive Surgery, Cosmetology and Cell Technology, Pirogov Russian National Research Medical University (RNRMU), 117997 Moscow, Russia.
Background/objectives: The aim was to study the possibilities of biomedical application of gadolinium oxide nanoparticles (GdO NPs) synthesized under industrial conditions, and evaluate their physicochemical properties, redox activity, biological activity, and safety using different human cell lines.
Methods: The powder of GdO NPs was obtained by a process of thermal decomposition of gadolinium carbonate precipitated from nitrate solution, and was studied using transmission electron microscopy (TEM), X-ray diffraction (XRD), Raman spectroscopy, mass spectrometry, and scanning electron microscopy (SEM) with energy dispersive X-ray analyzer (EDX). The redox activity of different concentrations of GdO NPs was studied by the optical spectroscopy (OS) method in the photochemical degradation process of methylene blue dye upon irradiation with an optical source.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!